No Data
No Data
Goldman's 'Buyback' Basket: CMCSA, GM, MPC, Etc
Goldman's High Growth Investment Ratio Stocks: EA, AMZN, FANG, Etc
TD Cowen Maintains Incyte(INCY.US) With Buy Rating, Maintains Target Price $80
Incyte (INCY) Gets a Buy From TD Cowen
Possible Bearish Signals With Incyte Insiders Disposing Stock
Express News | Incyte Announces Health Canada Approval of Opzelura (Ruxolitinib) Cream for Treatment of Atopic Dermatitis (Ad) and Nonsegmental Vitiligo
No Data
No Data